Compound 1012
Identifiers
- Canonical SMILES:
OC(=O)[C@H]1CCCN(C1)c1ccccc1Sc1ccc(cc1C(F)(F)F)[C@@H]1C[C@H]1C(=O)NCCCN1CCCC1=O
- IUPAC name:
1-[2-[4-[2-[3-(2-oxopyrrolidin-1-yl)propylcarbamoyl]cyclopropyl]-2-(trifluoromethyl)phenyl]sulfanylphenyl]piperidine-3-carboxylic acid
- InChi:
InChI=1S/C30H34F3N3O4S/c31-30(32,33)23-16-19(21-17-22(21)28(38)34-12-5-15-35-13-4-9-27(35)37)10-11-25(23)41-26-8-2-1-7-24(26)36-14-3-6-20(18-36)29(39)40/h1-2,7-8,10-11,16,20-22H,3-6,9,12-15,17-18H2,(H,34,38)(H,39,40)/t20-,21-,22+/m0/s1
- InChiKey:
RDDGVDXVIDYSSC-FDFHNCONSA-N
External links
168318114 |
19174415 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 7.30 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 589.22 g/mol | |||
HBA | 7 | |||
HBD | 2 | |||
HBA + HBD | 9 | |||
AlogP | 3.96 | |||
TPSA | 89.95 | |||
RB | 11 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5743 | Periciazine | DB01608 | |
0.5283 | Butaperazine | DB13213 | |
0.5066 | Propiopromazine | DB11540 | |
0.5031 | Carphenazine | DB01038 | |
0.4964 | Mequitazine | DB01071 | |
0.4861 | Etymemazine | DB11517 | |
0.4859 | Avacopan | DB15011 | |
0.4828 | Triflupromazine | DB00508 | |
0.4810 | Metopimazine | DB13591 | |
0.4808 | Fluphenazine | DB00623 | |
0.4803 | Trifluoperazine | DB00831 | |
0.4768 | Acepromazine | DB01614 | |
0.4753 | Acetophenazine | DB01063 | |
0.4684 | Propiomazine | DB00777 | |
0.4678 | Ezetimibe | DB00973 |